Pharming Group N.V. (PHAR) — research page
US · us-cm-kg/NASDAQ/PHAR · as of 2026-11-08
Identity and listing
The issuer is Pharming Group N.V., listed on NASDAQ under ticker PHAR, with ISIN US71716E1055 and LEI 724500DCJ9MPG74JEH91. Its security type is recorded as non-operating entity type (other), and its segment is not on the record. Its sector is 2834 Pharmaceutical Preparations and its jurisdiction is the Netherlands. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Pharming Group N.V. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | PHAR | source · 2026-11-08 |
| ISIN | US71716E1055 | source · 2026-09-25 |
| LEI | 724500DCJ9MPG74JEH91 | source · 2026-11-08 |
| security type | Non-operating entity type (other) | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | Netherlands | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 25 filings in the window 2025-11-08 to 2026-11-08, on 23 filing days, all of type results. The median gap between filing days is 10.5 days. The latest filing is dated 2026-11-06, 2 days before the record date, and is of type results. The NASDAQ median cadence gap is 6.0 days with a median of 52 filings and a median latency of 5.0 days. The sector median cadence gap is 6.0 days with a median of 63.0 filings and a median latency of 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 25 | 10.5 | 2 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | results | 6-K | 6-K — 6-K |
| 2026-10-27 | results | 6-K | 6-K — 6-K |
| 2026-10-22 | results | 6-K | 6-K — 6-K |
| 2026-10-14 | results | 6-K | 6-K — 6-K |
| 2026-09-29 | results | 6-K | 6-K — 6-K |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted.
Orderability
The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The record holds eight research houses named on the issuer's investor-relations page: Oppenheimer & Co. Inc., Portzamparc / BNP Paribas, Canaccord Genuity, First Berlin Research, H.C. Wainwright, Jefferies, Van Lanschot Kempen and RBC Capital Markets.
| research house | analyst | source · read date |
|---|---|---|
| Oppenheimer & Co. Inc. | Joseph Pantginis | issuer page · 2026-11-11 |
| Portzamparc / BNP Paribas | Sushila Hernandez | issuer page · 2026-11-11 |
| Canaccord Genuity | Whitney Ijem | issuer page · 2026-11-11 |
| First Berlin Research | Simon Scholes | issuer page · 2026-11-11 |
| H.C. Wainwright | Joseph Pantginis | issuer page · 2026-11-11 |
| Jefferies | Benjamin Jackson | issuer page · 2026-11-11 |
| Van Lanschot Kempen | Sushila Hernandez | issuer page · 2026-11-11 |
| RBC Capital Markets | Harry Sephton | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001828316.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/PHAR (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://www.pharming.com/investors/analyst-coverage (coverage)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/PHAR (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US71716E1055"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:330ce919654bb66d.